Dual Molecular Actions of Aspirin on Pancreatic β-Cell Function and Hepatic Glucose Transport in Experimental Diabetes
Jentashapir Journal of Cellular and Molecular Biology · 30.03.2026 · 17 (1)
DOI: 10.5812/jjcmb-168632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jentashapir Journal of Cellular and Molecular Biology, online erschienen am 30.03.2026. Verfasst von Mohammad Reza Mirzaei und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Aspirin (acetylsalicylic acid), a nonsteroidal anti-inflammatory drug, has been shown to modulate inflammatory and metabolic pathways.
Objectives
This study aimed to investigate the molecular effects of aspirin on pancreatic and hepatic gene expression associated with β-cell function and glucose regulation in alloxan-induced diabetic rats.
Methods
Twenty-four male Wistar rats were allocated to the control, diabetic, and diabetic-aspirin groups. Rats in the diabetic-aspirin group received aspirin (100 mg/kg/day, intraperitoneally) for 35 days. Fasting blood glucose (FBG), body weight, and the mRNA expression of Pdx1, Ins1/2, Insr, and Tnfα in pancreatic tissue, as well as Glut1, Glut2, Insr, and Tnfα in hepatic tissue, were analyzed using quantitative real-time polymerase chain reaction.
Results
Diabetes induction significantly increased FBG levels and dysregulated the expression of genes involved in insulin synthesis, glucose transport, and inflammation. Aspirin administration markedly reduced FBG by approximately 30% without affecting body weight, restored pancreatic Pdx1 and Ins1/2 expression, and downregulated Insr and Tnfα, indicating improved β-cell function and reduced local inflammation. In hepatic tissue, aspirin significantly suppressed the overexpression of Glut1, Glut2, Insr, and Tnfα, suggesting improved hepatic glucose handling and attenuated inflammatory signaling. These organ-specific transcriptional effects indicate that aspirin simultaneously supports β-cell regeneration and modulates hepatic glucose transport and inflammatory pathways. Mechanistically, these effects may be mediated through inhibition of the nuclear factor kappa B pathway, activation of AMP-activated protein kinase, and reduction of oxidative stress.
Conclusions
Collectively, these findings provide molecular evidence that aspirin may exert beneficial antidiabetic and anti-inflammatory effects by restoring pancreatic β-cell gene expression and normalizing hepatic metabolic gene networks, thereby supporting its potential as an accessible adjunct therapy for diabetes management.
Zitieren
APA
Mirzaei, M. R., Sisakhtnezhad, S., & Ghowsi, M. (2026). Dual Molecular Actions of Aspirin on Pancreatic β-Cell Function and Hepatic Glucose Transport in Experimental Diabetes. Jentashapir Journal of Cellular and Molecular Biology, 17(1). https://doi.org/10.5812/jjcmb-168632
Vancouver
Mirzaei MR, Sisakhtnezhad S, Ghowsi M. Dual Molecular Actions of Aspirin on Pancreatic β-Cell Function and Hepatic Glucose Transport in Experimental Diabetes. Jentashapir Journal of Cellular and Molecular Biology. 2026;17(1). doi:10.5812/jjcmb-168632
BibTeX
@article{Mirzaei2026,
author = {Mirzaei, Mohammad Reza and Sisakhtnezhad, Sajjad and Ghowsi, Mahnaz},
title = {Dual Molecular Actions of Aspirin on Pancreatic β-Cell Function and Hepatic Glucose Transport in Experimental Diabetes},
journal = {Jentashapir Journal of Cellular and Molecular Biology},
year = {2026},
volume = {17},
number = {1},
doi = {10.5812/jjcmb-168632}
}
EUVIMED